EC Status and Availability


EC ever use among women of reproductive age: 2.2% (DHS 1999)

EC knowledge among women of reproductive age: 33.4% (DHS 1999)

Contraceptive Use: 63.9% (DHS 1999, ever use of a modern method among women of reproductive age)

Registered LNG-EC products:

  • Escapelle* - Available only with prescription
  • Postinor* - Available only with prescription

Registered UPA-EC products:

  • Dvella* - Available only with prescription

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Public sector clinics, Pharmacies, Emergency room

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: No data available

Pricing information: LNG: € 5,54, as of 2014; UPA: € 15,10, as of 2014.

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search